Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Ahmed Eldefrawy is a urologic surgeon and researcher whose work centers on the comparative effectiveness, cost-efficiency, and surgical outcomes of treatments for urologic cancers and obstructive conditions. His major contributions lie in demonstrating the economic and clinical advantages of minimally invasive approaches, particularly robotic surgery. In a landmark 2011 study (63 citations), he showed that active surveillance for low-risk prostate cancer is significantly less costly than immediate treatment, providing critical data for shared decision-making. He further advanced the field by comparing robotic versus conventional laparoscopic pyeloplasty (58 citations) and by proving that robotic partial nephrectomy for larger T2a renal masses achieves superior “trifecta” outcomes—combining negative margins, minimal complications, and renal function preservation—compared to open surgery (28 citations). His cost analyses of nephron-sparing treatments for renal masses (53 citations) and urologist reimbursement patterns (11 citations) have informed both clinical practice and healthcare policy. Dr. Eldefrawy’s work is widely cited for its rigorous methodology and practical implications, making him a key voice in the shift toward value-based, patient-centered urologic care.